Impairment of microcirculation and vascular responsiveness in adolescents with primary Raynaud phenomenon

Table 1 Demographic and clinical characteristics of adolescents involved in the study

	Healthy	Raynaud without current symptoms	Raynaud with current symptoms
Number	25	15	12
Age (years)	16.5 ± 0.2 (14.8–19)	16.6 ± 0.4 (13.2–18.2)	16.2 ± 0.4 (13–18)
Duration of the disease (months)	–	23.2 ± 4.9 (2.4–54)	38.4 ± 6.9 (12–96)
Body fat composition (%)	24.0 ± 1.5 (4.3–41.8)	32.1 ± 2.7 (17.8–50.6)**	18.1 ± 1.7 (8.2–27.4)*, ^###
Body Mass Index (BMI)	22.0 ± 0.8 (17.3–35.1)	25.8 ± 1.9 (17.6–39.5)	18.78 ± 0.4 (15.8–20.8) *, ^##
Mean arterial blood pressure (mmHg)	87.5 ± 1.7 (73.3–107.0)	90.1 ± 1.6 (82–101.3)	81.7 ± 2.1 (71.7–97.0)*, ^#

Data represent the means±SEM, as well as the range of the data in each group (*p < 0.05, ** p < 0.01 vs. healthy; ^#p < 0.05, ^##p<0.01, ^###p < 0.001 vs. patients without current symptoms, Kruskal-Wallis test followed by Dunn’s multiple comparison test for body mass index values, one-way ANOVA followed by Neuman-Keuls multiple comparison test for all other parameters)

ISSN: 1546-0096